Bio Elpida, facilities dedicated to the development of bio-pharmaceuticals
120 m² of R&D Laboratories

Bio Elpida provides two types of R&D laboratories:
  • 60 m² dedicated to the research and development for prokaryote cell programmes
  • 60 m² dedicated to the research and development for eukaryotic cell programmes

Quality insurance and GMP rules are applied as early as R&D phases

A distinctive feature of Bio Elpida is to apply quality insurance and GMP as early as R&D phases. This approach ensures optimal transfer of processes to GMP manufacturing and pharmaceutical zones as well as scale-up.

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Development and Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.
Expertise
Services
R&D and Feasibility
Pharmaceutical Development
Single-Use Approach
Optimisation & Scale up
Analytical Method
Manufacturing and Control
Testing
Aseptic Fill & Finish
Support
Formulation
Regulation IMPD
Drug Analytical Development
Bulk Purification


Facilities
R&D Facilities
Feasibility Facilities
API Facilities
ATMP Facilities

Team


Company

News

Contact
Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •